Scarica l'app Stockscreener
2.40
1.69%
0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IBRX Giù?
Forum
Previsione
Precedente Chiudi:
$2.36
Aprire:
$2.37
Volume 24 ore:
6.79M
Relative Volume:
0.71
Capitalizzazione di mercato:
$2.27B
Reddito:
$1.31M
Utile/perdita netta:
$-597.65M
Rapporto P/E:
-2.4742
EPS:
-0.97
Flusso di cassa netto:
$-425.62M
1 W Prestazione:
-2.83%
1M Prestazione:
-2.44%
6M Prestazione:
-4.38%
1 anno Prestazione:
-53.93%
Intervallo 1D:
$2.33
$2.4351
Intervallo di 1 settimana:
$2.33
$2.67
Portata 52W:
$1.83
$5.88
Immunitybio Inc Stock (IBRX) Company Profile
Nome
Immunitybio Inc
Settore
Industria
Telefono
(844) 696-5235
Indirizzo
3530 JOHN HOPKINS COURT, SAN DIEGO
Confronta IBRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.40 | 2.32B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-10 | Iniziato | BTIG Research | Buy |
| 2023-05-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | Iniziato | Jefferies | Buy |
Immunitybio Inc Borsa (IBRX) Ultime notizie
ImmunityBio Inc. recovery potential after sell off2025 Momentum Check & Verified High Yield Trade Plans - newser.com
Will ImmunityBio Inc. (26CA) stock justify high valuationQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
What moving averages say about ImmunityBio Inc.2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
How ImmunityBio Inc. (26CA) stock compares with tech leadersQuarterly Investment Review & Daily Growth Stock Tips - newser.com
Why ImmunityBio Inc. (26CA) stock stays undervaluedGap Up & Weekly Setup with High ROI Potential - newser.com
How ImmunityBio Inc. (26CA) stock responds to bond marketJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionJuly 2025 Patterns & Verified Technical Signals - newser.com
ImmunityBio, Inc. (IBRX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Applying big data sentiment scoring on ImmunityBio Inc.Bear Alert & Safe Capital Growth Tips - newser.com
ImmunityBio, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Tick level data insight on ImmunityBio Inc. volatility2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Will ImmunityBio Inc. stock continue upward momentum2025 Sector Review & Safe Entry Point Alerts - newser.com
Why retail investors favor ImmunityBio Inc. stock2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Can machine learning forecast ImmunityBio Inc. recoveryWatch List & High Accuracy Swing Entry Alerts - newser.com
What drives ImmunityBio Inc 26CA stock priceIPO Market Watch & Low Risk Capital Appreciation - earlytimes.in
How hedge fund analytics apply to ImmunityBio Inc. stockPortfolio Update Summary & Reliable Entry Point Trade Alerts - newser.com
Is ImmunityBio Inc. stock a buy on dipsWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com
Why ImmunityBio Inc. (26CA) stock is a strong analyst pickPortfolio Value Summary & High Yield Stock Recommendations - newser.com
ImmunityBio And 2 Other Stocks That May Be Priced Below Their Estimated Worth - Yahoo! Finance Australia
NK Cell Therapy Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Amgen, ImmunityBio, Dragonfly Therapeutics, Glycostem Therapeutics, Athenex - Barchart.com
NK Cell Therapy Pipeline 2025: MOA and ROA Insights, Clinical - openPR.com
Immunitybio Inc Azioni (IBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):